Efficacy and safety of etrasimod in alopecia areata: A multicentre, randomized, double‐blind, placebo‐controlled, Phase 2 study

Authors

Institutions

Publication Details

Journal
Journal of the European Academy of Dermatology and Venereology
Published
2025-03-27
DOI
https://doi.org/10.1111/jdv.20605
Citations
3
Primary Topic
Hair Growth and Disorders
Type
article
Field-Weighted Citation Impact
5.51

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy and safety of etrasimod in alopecia areata: A multicentre, randomized, double‐blind, placebo‐controlled, Phase 2 study

Natasha Atanaskova Mesinkovska, Maryanne M. Senna, Andrew Selfridge, Brett King et al.
3 citations
Journal of the European Academy of Dermatology and Venereology
Hair Growth and Disorders
5.51
article

Efficacy and safety of etrasimod in alopecia areata: A multicentre, randomized, double‐blind, placebo‐controlled, Phase 2 study

Natasha Atanaskova Mesinkovska, Maryanne M. Senna, Andrew Selfridge, Brett King, Xin Luo, J. Minkiewicz
article en
3 citations

Abstract

No abstract available for this paper.
Journal of the European Academy of Dermatology and VenereologyVol. 39(6)
Pfizer (United States) (US), Lahey Medical Center (US), Pfizer (China) (CN)
Pfizer
Openalex Percentile: Top 5%
Hair Growth and Disorders
5.51
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.